Xopenex HFA (Levalbuterol tartrate) for asthma

Overview
Xopenex HFA is a prescription drug approved by the U.S. Food and Drug Administration (FDA) to prevent and treat bronchospasms for people with reversible obstructive airway disease ages 4 and older. Xopenex is also known by its drug name, Levalbuterol tartrate.

Chemically, Xopenex is very similar to Albuterol. Xopenex is a bronchodilator, a drug that dilates the bronchi and bronchioles in the lungs, making it easier to breathe. Xopenex is believed to work by relaxing smooth muscles in the airways. Xopenex is considered a short-acting bronchodilator.

How do I take it?
Xopenex is typically taken every four to six hours.

Xopenex is taken orally using an inhaler or nebulizer.

Side effects
Common side effects of Xopenex include bronchitis, vomiting, throat irritation, muscle pain, and dizziness.

Rare but serious side effects listed for Xopenex include cardiovascular effects, paradoxical bronchospasm (bronchospasm caused by taking medication), hypersensitivity reactions, and changes in blood glucose levels. Excessive use can be fatal.

For more details about this treatment, visit:
Xopenex HFA Prescribing Information
www.accessdata.fda.gov/drugsatfda_docs/label/2013/021730s033lbl.pdf